Noopept, single vial

Racetam-family nootropic

Noopept

Classification is genuinely ambiguous. Built on a proline-glycine dipeptide backbone, so it contains a peptide bond, but heavily modified with a phenylacetyl group and an ethyl ester. Commonly classified with racetam-family small molecules rather than with amino-acid-chain peptides.. Supplied for laboratory research use only.

  • Structurally ambiguous -- modified dipeptide, often classed as small molecule
  • Approved as a prescription nootropic in Russia
  • 2019 FDA warning letter named it an unapproved new drug
  • Supplied for laboratory research use only. Not for human or veterinary use.
$239.99$359.97 Save 33%
Choose your supply
Most Popular
Best Value
In stock, ready to ship

90-Day Money-Back Guarantee

Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.

Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

What it is
CompoundNoopept, also designated GVS-111
ClassRacetam-family nootropic
CompositionClassification is genuinely ambiguous. Built on a proline-glycine dipeptide backbone, so it contains a peptide bond, but heavily modified with a phenylacetyl group and an ethyl ester. Commonly classified with racetam-family small molecules rather than with amino-acid-chain peptides.
FormCapsules or raw powder, supplied in a vial
OriginatorV. V. Zakusov Institute of Pharmacology
Development status

Noopept is not approved by the FDA for any indication.

Development status is stated above. No efficacy claim is made on this page.

Shipping & returns
ReturnsNinety days from delivery. Contact us and we will refund the purchase price.
Noopept $239.99

The specifics

The details, if you want them.

DeveloperV. V. Zakusov Institute of Pharmacology (Russia)
Also known asGVS-111
ClassRacetam-family nootropic (proline-glycine dipeptide-derived)
Molecule typeA genuine edge case — contains a peptide bond but is heavily modified; commonly classified with small molecules, not peptides
Regulatory historyApproved as a prescription drug in Russia; unscheduled in the US
FormCapsule or raw powder (not a reconstituted vial)
Receptor target(s)Proposed AMPA/NMDA glutamate receptor modulation; mechanism not fully established

Development

Where it is up to.

Approved in Russia as a prescription drug. No FDA/EMA/MHRA/TGA-standard trial result is presented here.

Questions

The questions people actually ask.

What is Noopept?
A synthetic compound built on a proline-glycine dipeptide backbone, so heavily modified that it's usually classed with small-molecule nootropics, not true peptides.
Is Noopept actually a peptide?
It's a genuine edge case: it contains one peptide bond but is heavily modified. Most sources classify it with racetam-family small molecules rather than amino-acid-chain peptides.
Is Noopept approved by the FDA?
No. It's a prescription drug in Russia, but unscheduled in the US, where FDA issued a 2019 warning letter finding it an unapproved new drug.
What does "Research Use Only" mean?
Research Use Only means exactly that: intended for laboratory and research settings only, not for human or animal use, consumption, diagnosis, treatment, cure, or prevention of any disease.
What is your refund policy?
Ninety days from delivery. If you decide against it inside that window, contact hello@getmrpeps.com and we will refund the purchase price. Damaged or incorrect orders are replaced or refunded regardless.